Back to top
more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$600.02 USD

600.02
357,968

+3.10 (0.52%)

Updated Oct 14, 2024 02:12 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Bio-Rad (BIO) Q3 Earnings Surpass Estimates, 2021 View Raised

Strength in the Life Science and Clinical Diagnostics segments drove Bio-Rad's (BIO) revenues in the third quarter.

DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates

DexCom's (DXCM) third-quarter results benefit from domestic and international revenue growth and solid new customer additions.

Stryker (SYK) Earnings and Revenues Miss Estimates in Q3

Despite pandemic-led disruptions, Stryker's (SYK) third-quarter earnings reflect strong performance across Orthopaedics, MedSurg and Neurotechnology and Spine segments.

ResMed (RMD) Q1 Earnings Top Estimates, Margins Decline

ResMed (RMD) reports better-than-expected earnings and revenues with robust demand for sleep and respiratory care devices driving Q1 top line.

DaVita (DVA) Beats on Q3 Earnings, Narrows 2021 EPS View

DaVita's (DVA) strength in dialysis patient service revenues drives its Q3 top line.

Teleflex (TFX) Q3 Earnings Top Estimates, Full-Year EPS View Up

Teleflex (TFX) reports better-than-expected earnings and revenues with strong geographical performance driving the top line in third-quarter 2021.

Thermo Fisher (TMO) Hits Fresh High: Is There Still Room to Run?

Thermo Fisher (TMO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Has Thermo Fisher Scientific (TMO) Outpaced Other Medical Stocks This Year?

Is (TMO) Outperforming Other Medical Stocks This Year?

Thermo Fisher (TMO) Beats on Q3 Earnings, Raises 2021 View

Thermo Fisher (TMO) delivers a strong quarterly performance, leveraging on a significant rebound in its base business.

Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Thermo Fisher Scientific (TMO) Q3 Earnings and Revenues Beat Estimates

Thermo Fisher (TMO) delivered earnings and revenue surprises of 23.34% and 11.96%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

The Zacks Analyst Blog Highlights: Capital One Financial, Thermo Fisher Scientific, Aflac, DexCom and Exxon Mobil

The Zacks Analyst Blog Highlights: Capital One Financial, Thermo Fisher Scientific, Aflac, DexCom and Exxon Mobil

Urmimala Biswas headshot

Medical Products Stock Q3 Earnings on Oct 27: TMO, EW & More

With the pandemic raging on, testing, vaccine and therapeutic makers witness huge market adoption of their COVID-related support products in Q3.

Nalak Das headshot

5 S&P 500 Stocks to Buy Ahead of Q3 Earnings This Week

Five big S&P 500 companies (market capital > $45 billion) are slated to release third-quarter earnings results this week. These are: COF, DXCM, XOM, AFL and TMO.

Abbott's (ABT) Organic Sales Grow Amid Spike in COVID Cases

Within Nutrition, the robust year-over-year performance of Abbott's (ABT) U.S. pediatric and international adult nutrition arms drives the company in the third quarter.

Why Thermo Fisher (TMO) Might Surprise This Earnings Season

Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

STERIS (STE) Hits a New 52-Week High: What's Driving It?

Strong performance by the Healthcare, AST and Life Sciences segments is driving the top line for STERIS (STE).

The Zacks Analyst Blog Highlights: Alphabet, Netflix, Thermo Fisher Scientific, Wells Fargo and Novartis

The Zacks Analyst Blog Highlights: Alphabet, Netflix, Thermo Fisher Scientific, Wells Fargo and Novartis

Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know

Thermo Fisher Scientific (TMO) closed the most recent trading day at $608.41, moving +0.46% from the previous trading session.

Sheraz Mian headshot

Top Stock Reports for Alphabet, Netflix & Thermo Fisher

Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Netflix, Inc. (NFLX), and Thermo Fisher Scientific Inc. (TMO).

Teladoc (TDOC) to Report Q3 Earnings: What's in the Cards?

Robust customer uptake and novel innovations are likely to have contributed to growth for Teladoc (TDOC).

Thermo Fisher Scientific (TMO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PerkinElmer (PKI) Receives EUA from FDA for Latest Assay

PerkinElmer's (PKI) latest test receives EUA from the FDA, thereby enabling qualified laboratories to detect and differentiate SARS-CoV-2, influenza A, influenza B and RSV.

Quest Diagnostics (DGX) Base Arm Recovers, Testing Sales Grow

Quest Diagnostics (DGX) is hopeful about the fact that COVID-19 testing remains critical as employees are returning to the workplace and students to the classroom.

Thermo Fisher Scientific (TMO) Gains But Lags Market: What You Should Know

Thermo Fisher Scientific (TMO) closed the most recent trading day at $577.35, moving +0.66% from the previous trading session.